Raphael Deferiere

Insider Reports History

Location
Cheshire
Signature
/s/ Gregory Weinhoff, attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Raphael Deferiere:

Company Role Class Num Shares Value Price $ Report Date Ownership
Centessa Pharmaceuticals plc Chief Accounting Officer Share Option (right to buy) 165,000 02 Jun 2025 Direct

Insider Reports Filed by Raphael Deferiere

Symbol Company Period Transactions Value $ Form Type Role Filing Time
CNTA Centessa Pharmaceuticals plc 02 Jun 2025 1 $0 4 Chief Accounting Officer 03 Jun 2025, 16:26
CNTA Centessa Pharmaceuticals plc 27 May 2025 0 $0 3 Chief Accounting Officer 03 Jun 2025, 16:24